Urologix Stock Working Capital
| ULGXDelisted Stock | USD 0.0001 0.00 0.00% |
Urologix fundamentals help investors to digest information that contributes to Urologix's financial success or failures. It also enables traders to predict the movement of Urologix Pink Sheet. The fundamental analysis module provides a way to measure Urologix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Urologix pink sheet.
Urologix |
Urologix Company Working Capital Analysis
Urologix's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Urologix Working Capital | (612 K) |
Most of Urologix's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Urologix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAs per the company's disclosures, Urologix has a Working Capital of (612,000). This is 100.14% lower than that of the Health Care Equipment & Supplies sector and 100.04% lower than that of the Health Care industry. The working capital for all United States stocks is 100.04% higher than that of the company.
Urologix Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Urologix's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Urologix could also be used in its relative valuation, which is a method of valuing Urologix by comparing valuation metrics of similar companies.Urologix is currently under evaluation in working capital category among its peers.
Urologix Fundamentals
| Return On Asset | -0.0762 | ||||
| Profit Margin | (0.39) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 4.92 M | ||||
| Shares Outstanding | 21.82 M | ||||
| Number Of Shares Shorted | 41.23 K | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 14.01 M | ||||
| Gross Profit | 5.9 M | ||||
| EBITDA | (373 K) | ||||
| Net Income | (7.61 M) | ||||
| Cash And Equivalents | 492 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 4.59 M | ||||
| Debt To Equity | (1.81) % | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (0.38) X | ||||
| Cash Flow From Operations | (1.53 M) | ||||
| Short Ratio | 1.02 X | ||||
| Earnings Per Share | (0.22) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 61 | ||||
| Beta | -80.48 | ||||
| Market Capitalization | 82.91 K | ||||
| Total Asset | 5.67 M | ||||
| Retained Earnings | (126.63 M) | ||||
| Working Capital | (612 K) | ||||
| Current Asset | 3.68 M | ||||
| Current Liabilities | 4.29 M | ||||
| Z Score | -28.8 | ||||
| Net Asset | 5.67 M |
About Urologix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Urologix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Urologix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Urologix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Urologix Pink Sheet
If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |